Key points are not available for this paper at this time.
Evidence supports using antiplatelet therapy in patients with acute ischemic stroke. However, neurological deterioration remains common under the currently recommended antiplatelet regimen, leading to poor clinical outcomes.
Zhao et al. (Mon,) studied this question.